Tilletia controversa
Tilletia controversa is a species of fungus that belongs to the Tilletiaceae family. It is commonly known as the dwarf bunt and is a significant pathogen of wheat crops.
Taxonomy
The species was first described by the American mycologist Albert Julius Winkler in 1898. It belongs to the genus Tilletia, which comprises around 150 species of fungi that are known to cause bunt diseases in grasses.
Description
Tilletia controversa is characterized by its production of teliospores, which are thick-walled, dark brown, and spherical. The teliospores are typically 20-30 µm in diameter and have a reticulate surface pattern. The fungus also produces basidiospores, which are smaller and lighter in color.
Life Cycle
The life cycle of Tilletia controversa involves two main stages: the teliospore stage and the basidiospore stage. The teliospores are the primary means of dispersal and can survive in the soil for several years. When conditions are favorable, the teliospores germinate and produce basidiospores, which can infect wheat plants.
Pathogenicity
Tilletia controversa is a significant pathogen of wheat, causing a disease known as dwarf bunt. The disease is characterized by the replacement of the wheat kernels with masses of teliospores, resulting in a reduction in yield and quality. The disease is most prevalent in regions with cold winters, as the teliospores require a period of cold stratification to germinate.
Management
Management of Tilletia controversa involves a combination of cultural practices and chemical control. Cultural practices include crop rotation and the use of resistant wheat varieties. Chemical control involves the use of fungicides, which can be applied to the soil or to the wheat seeds.
See Also
References
- Winkler, A.J. (1898). Tilletia controversa, a new species of bunt. Journal of Mycology, 4(2), 67-70.
- Mathre, D.E. (1997). Compendium of barley diseases. St. Paul, MN: APS Press.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD